Clinical trial
Intra-lesional ACE Inhibitor for Treatment of Hypertrophic Scars
NCT05259137 is registered in ClinicalTrials.gov with Nova Scotia Health Authority as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intra-lesional ACE Inhibitor for Treatment of Hypertrophic Scars
- Lead sponsor
- Nova Scotia Health Authority
- Phase
- Phase 2/3
- Overall status
- Withdrawn
- Start date
- August 31, 2024
- Completion date
- October 31, 2026
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
hypertrophic scar